Heparin
is used to prevent or treat certain blood vessel, heart, and lung
conditions. It is also used in blood transfusion, blood samplings
during prophylaxis treatment, and for treatment of blood clotting
disorders Heparin may be used to diagnose and treat a serious blood
condition called disseminated intravascular coagulation. Heparin is
sometimes used alone or in combination with aspirin to prevent
pregnancy loss and other problems.
The
global heparin market size was valued at US$ 9.4 billion in 2017 and
is expected to witness a CAGR of 5.1% over the forecast period (2018
– 2026).
Request
a Sample of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2602
Increasing
incidences of coronary heart disease, pulmonary embolism, and deep
vein thrombosis is expected to drive growth of the heparin market
Heparin
is widely used clinically for dialysis, deep vein thrombosis (DVT)
treatment, and most cardiac surgeries. It is also used to prevent
blood clotting during open-heart surgery, kidney dialysis, bypass
surgery, and blood transfusions. Kidney dialysis procedure is
increasing with rising chronic kidney disease, worldwide. For
instance, according to Kidney Care UK 2016 report, about 3 million
people in the U.K. are suffering from chronic kidney disease (CKD).
Furthermore,
increasing number of surgeries and rising prevalence of diseases such
as deep vein thrombosis and coronary heart disease, are fueling
demand for heparin, eventually driving growth of the heparin market,
during the forecast period. According to the American Heart
Association 2018 report, coronary heart disease accounts for 1 in 7
deaths in the U.S., killing over 366,800 people every year. As per
the same source, the overall prevalence for myocardial infarction
(MI) in the U.S. is about 7.9 million, or 3 percent in U.S. adults.
Heparin
Market - Regional Insights
On
the basis of region, the global heparin market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa. Europe heparin market is expected to generate significant
revenue share during the forecast period, owing to growing geriatric
population and rising prevalence of long-term survivors of acute
myocardial infarction (AMI). Survivors of AMI are at high risk of a
recurrent myocardial infarction, as well as other manifestations of
cardiovascular disease such as stroke. According to Lancet journal,
2017 report, acute myocardial infarction is the leading cause of
hospital admissions and mortality in the UK and across the world.
Heparin
Market - Competitive Landscape
Key
players operating in the global heparin market include Anselm
Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG,
Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius
SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc.,
Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and
United Biotech (P) Ltd.
Detailed
Segmentation:
Global
Heparin Market, By Product Type:
-
Unfractionated Heparin (UH)
-
Low Molecular Weight Heparin (LMWH)
-
Ultra-low Molecular Weight Heparin (ULMW)
Global
Heparin Market, By Dosage Form:
-
Injection
-
Solutions
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/market-insight/heparin-market-2602
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment